The impact of antibodies to human glycoprotein CD4 and gamma-interferon on the t-cell immunity and the cytokine levels in patients co-infected with HIV/HCV during the antiretroviral therapy

Objective: This work was to estimate the influence of antibodies to human glycoprotein CD4 and IFN-γ on the T-cell immunity and the cytokine levels in patients with HIV and HIV/HCV during the standard antiretroviral therapy. Materials and methods: Randomized clinical trial in parallel groups. 4 groups were included: patients with HIV receiving ART (20) or ART and antibodies (AB) (19) for 3 months; patients with HIV/HCV, receiving ART (17) or ART and AB (20) for 3 months. The obtained data included: CD3+, CD4+, CD8+ cell count; IFN-γ, IL-2 and IL-4 concentrations; HIV viral load. Results: The significant increase of CD4+ cell number and IFN-γ were found in patients receiving ART and antibodies. These changes were followed with more significant decline in the viral load. Conclusion: The antibodies to human glycoprotein CD4 and IFN-γ added to standard ART increased the CD4+ cell count and IFN-γ levels in patients with HIV/HCV, followed by the trend to increase the number of patients with viral load >50 ml-1. Thus, the administration of ART supplemented with antibodies to human glycoprotein CD4 and IFN-γ resulted in the increase of antiviral immunity. Further clinical trials in HIV or HIV patients with co-infections could be recommended.

1. Allers K, Hütter G, Hofmann J, Loddenkemper C, Rieger K, Thiel E, et al. Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation. Blood. 2011;117(10)2791-9. doi: 10.1182/blood-2010-09-309591

2. Hütter G, Nowak D, Mossner M, Ganepola S, Müssig A, Allers K, et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N. Engl. J. Med. 2009;360(7):692-8. doi: 10.1056/NEJMoa0802905

3. Olson WC, Jacobson JM. CCR5 monoclonal antibodies for HIV-1 therapy. Curr. Opin. HIV AIDS. 2009;4(2):104-11. doi: 10.1097/COH.0b013e3283224015

4. Tebas P, Stein D, Tang WW, Frank I, Wang SQ, Lee G, et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N. Engl. J. Med. 2014;370(10):901-10. doi: 10.1056/NEJMoa1300662

5. Alkhatib G. The biology of CCR5 and CXCR4. Curr. Opin. HIV AIDS. 2009;4(2):96-103. doi: 10.1097/ COH.0b013e328324bbec

6. Bai Y, Xue H, Wang K, Cai L, Qiu J, Bi S, et al. Covalent fusion inhibitors targeting HIV-1 gp41 deep pocket. Amino Acids. 2013;44(2):701-13. doi: 10.1007/s00726-012-1394-8

7. Chu C, Selwyn PA. Complications of HIV infection: a systems-based approach. Am. Fam. Physician. 2011;83(4):395- 406.

8. Copeland KF. Modulation of HIV-1 transcription by cytokines and chemokines. Mini Rev. Med. Chem. 2005;5(12):1093-101.

9. Strygin AV, Nesmiyanov PP, Strygina AO. Influence of antibodies to gamma-interferon on the cell immunity and cytokine profile of HIV-infected patients. Russian allergology journal. 2012;(1):298-299. (in Russ.)

10. Epstein OI, Sherstoboev EY, Martyushev-Poklad AV, Dugina YL, Sergeeva SA, Dygai AM. Dose-dependent effects and specificity of action of antibodies to endogenous regulators in ultralow doses. Bull. Exp. Biol. Med. 2004;137:460-2.

11. Strygin AV, Strygina AO, Morkovin EI. Effects of human yinterferon and CD4 glycoprotein antibodies on the immune system indices in HIV-infected patients. Vestnik VolgGMU. 2017;1(61):46-49. (in Russ.)

12. May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S, et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS. 2014;28(8):1193-202. doi: 10.1097/ QAD.0000000000000243

13. Alimonti JB, Ball TB, Fowke KR. Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J. Gen. Virol. 2003;84(7):1649-61. doi: 10.1099/vir.0.19110-0

14. Campbell GR, Watkins JD, Esquieu D, Pasquier E, Loret EP, Spector SA. The C terminus of HIV-1 Tat modulates the extent of CD178-mediated apoptosis of T cells. J. Biol. Chem. 2005;280(46):38376-82. doi: 10.1074/jbc.M506630200

15. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525-33. doi: 10.1016/S0140-6736(13)61809-7